Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xilio Therapeutics (XLO) Asset Utilization Ratio (2024 - 2025)

Xilio Therapeutics (XLO) has disclosed Asset Utilization Ratio for 2 consecutive years, with 0.3 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 248.63% to 0.3 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.3 through Dec 2025, up 248.63% year-over-year, with the annual reading at 0.39 for FY2025, N/A changed from the prior year.
  • Asset Utilization Ratio hit 0.3 in Q4 2025 for Xilio Therapeutics, up from 0.24 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.3 in Q4 2025 to a low of 0.09 in Q4 2024.